| Novoseven, Novoseven Rt |
103665 |
001 |
351(a) |
Coagulation Factor VIIa (Recombinant) |
For Injection |
Intravenous |
2.4MG |
Single-Dose Vial |
1999/03/25
|
Novo Nordisk Inc. |
Disc |
Licensed |
|
N/A |
| Actimmune |
103836 |
001 |
351(a) |
interferon gamma-1b |
Injection |
Subcutaneous |
100MCG(2MILLION INTERNATIONAL UNITS)/0.5ML |
Single-Dose Vial |
1999/02/25
|
Horizon Therapeutics Ireland DAC |
Rx |
Licensed |
N/A |
N/A |
| Ontak |
103767 |
001 |
351(a) |
denileukin diftitox |
Injection |
Intravenous |
150MCG/ML (300MCG/2ML) |
Single-Dose Vial |
1999/02/05
|
Eisai, Incorporated |
Disc |
Licensed |
N/A |
N/A |
| Humatrope |
019640 |
005 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
6MG |
Multi-Dose Cartridge |
1999/02/04
|
Eli Lilly and Company |
Rx |
Licensed |
N/A |
N/A |
| Humatrope |
019640 |
006 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
12MG |
Multi-Dose Cartridge |
1999/02/04
|
Eli Lilly and Company |
Rx |
Licensed |
N/A |
N/A |
| Humatrope |
019640 |
007 |
351(a) |
somatropin |
For Injection |
Subcutaneous |
24MG |
Multi-Dose Cartridge |
1999/02/04
|
Eli Lilly and Company |
Rx |
Licensed |
N/A |
N/A |
| Thyrogen |
020898 |
001 |
351(a) |
thyrotropin alfa |
For Injection |
Intramuscular |
0.9MG |
Single-Dose Vial |
1998/11/30
|
Genzyme Corporation |
Rx |
Licensed |
N/A |
N/A |
| Biorab |
103820 |
001 |
351(a) |
Rabies Vaccine Adsorbed |
Injection |
Intramuscular |
1.0ML |
Vial |
1998/11/12
|
Emergent BioDefense Operations Lansing LLC |
Disc |
Licensed |
|
N/A |
| Biothrax |
103821 |
001 |
351(a) |
Anthrax Vaccine Adsorbed |
Injection |
Intramuscular |
0.5ML |
Multi-Dose Vial |
1998/11/12
|
Emergent BioDefense Operations Lansing LLC |
Rx |
Licensed |
|
N/A |
| Biothrax |
103821 |
002 |
351(a) |
Anthrax Vaccine Adsorbed |
Injection |
Subcutaneous |
0.5ML |
Multi-Dose Vial |
1998/11/12
|
Emergent BioDefense Operations Lansing LLC |
Rx |
Licensed |
|
N/A |
| Fluvirin |
103837 |
001 |
351(a) |
Influenza Virus Vaccine |
Injection |
Intramuscular |
15UG/.5ML |
Pre-Filled Syringe |
1998/11/03
|
Seqirus Vaccines Limited |
Disc |
Licensed |
|
N/A |
| Enbrel |
103795 |
001 |
351(a) |
etanercept |
For Injection |
Subcutaneous |
25MG |
Single-Dose Vial |
1998/11/02
|
Immunex Corporation |
Disc |
Licensed |
N/A |
N/A |
| Verluma |
103769 |
001 |
351(a) |
nofetumomab |
Injection |
Intravenous |
10MG/ML |
|
1998/10/13
|
Boehringer Ingelheim Pharma GmbH & Co. KG |
Disc |
Voluntarily Revoked |
N/A |
N/A |
| Herceptin |
103792 |
001 |
351(a) |
trastuzumab |
For Injection |
Intravenous |
420MG |
Multi-Dose Vial |
1998/09/25
|
Genentech, Inc. |
Disc* |
Licensed |
N/A |
N/A |
| Remicade |
103772 |
001 |
351(a) |
infliximab |
For Injection |
Intravenous |
100MG |
Single-Dose Vial |
1998/08/24
|
Janssen Biotech, Inc. |
Rx |
Licensed |
N/A |
N/A |
| Humulin R U-100 |
018780 |
003 |
351(a) |
insulin human |
Injection |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Autoinjector |
1998/08/06
|
Eli Lilly and Company |
Disc |
Licensed |
N/A |
N/A |
| Humalog |
020563 |
002 |
351(a) |
insulin lispro |
Injection |
Subcutaneous |
300UNITS/3ML (100UNITS/ML) |
Multi-Dose Cartridge |
1998/08/06
|
Eli Lilly and Company |
Disc |
Licensed |
N/A |
N/A |
| Infasurf |
020521 |
001 |
351(a) |
calfactant |
Suspension |
Intratracheal |
210MG/6ML (35MG/ML) |
Single-Dose Vial |
1998/07/01
|
ONY Biotech Inc. |
Rx |
Licensed |
N/A |
N/A |
| Synagis |
103770 |
001 |
351(a) |
palivizumab |
For Injection |
Intramuscular |
50MG |
Single-Dose Vial |
1998/06/19
|
Swedish Orphan Biovitrum AB (publ) |
Disc |
Licensed |
N/A |
N/A |
| Synagis |
103770 |
002 |
351(a) |
palivizumab |
For Injection |
Intramuscular |
100MG |
Single-Dose Vial |
1998/06/19
|
Swedish Orphan Biovitrum AB (publ) |
Disc |
Licensed |
N/A |
N/A |